The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Live Attenuated Influenza Viruses Containing NS1 Truncations as Vaccine Candidates against H5N1 Highly Pathogenic Avian Influenza
Open accessAbstract
Due to the high mortality associated with recent, widely circulating strains of H5N1 influenza virus in poultry, the recurring introduction of H5N1 viruses from birds to humans, and the difficulties in H5N1 eradication by elimination of affected flocks, an effective vaccine against HPAI (highly pathogenic avian influenza) is highly desirable. Using reverse genetics, a set of experimental live attenuated vaccine strains based on recombinant H5N1 influenza virus A/Viet Nam/1203/04 was generated. Each virus was attenuated through expression of a hemagglutinin protein in which the polybasic cleavage site had been removed. Viruses were generated which possessed a full-length NS1 or a C-terminally truncated NS1 protein of 73, 99, or 126 amino acids. Viruses with each NS genotype were combined with a PB2 polymerase gene which carried either a lysine or a glutamic acid at position 627. We predicted that glutamic acid at position 627 of PB2 would attenuate the virus in mammalian hosts, thus increasing the safety of the vaccine. All recombinant viruses grew to high titers in 10-day-old embryonated chicken eggs but were attenuated in mammalian cell culture. Induction of high levels of beta interferon by all viruses possessing truncations in the NS1 protein was demonstrated by interferon bioassay. The viruses were each found to be highly attenuated in a mouse model. Vaccination with a single dose of any virus conferred complete protection from death upon challenge with a mouse lethal virus expressing H5N1 hemagglutinin and neuraminidase proteins. In a chicken model, vaccination with a single dose of a selected virus encoding the NS1 1-99 protein completely protected chickens from lethal challenge with homologous HPAI virus A/Viet Nam/1203/04 (H5N1) and provided a high level of protection from a heterologous virus, A/egret/Egypt/01/06 (H5N1). Thus, recombinant influenza A/Viet Nam/1203/04 viruses attenuated through the introduction of mutations in the hemagglutinin, NS1, and PB2 coding regions display characteristics desirable for live attenuated vaccines and hold potential as vaccine candidates in poultry as well as in mammalian hosts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS12
REED, L. J., & MUENCH, H. (1938) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a118408 · Cited by 19,926
A simple method of estimating 50 per cent end points
Muench, H. (1938) · Medical Entomology and Zoology · Cited by 8,376
Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia
Li, K. S., Guan, Y., Wang, J., Smith, G. J. D., Xu, K. M., Duan, L., Rahardjo, A. P., Puthavathana, P., Buranathai, C., Nguyen, T. D., et al. (2004) · Nature · doi:10.1038/nature02746 · Cited by 1,343
Molecular Basis for High Virulence of Hong Kong H5N1 Influenza A Viruses
Hatta, M., Gao, P., Halfmann, P., & Kawaoka, Y. (2001) · Science · doi:10.1126/science.1062882 · Cited by 1,338
Avian Influenza Virus (H5N1): a Threat to Human Health
Peiris, J. S. M., de Jong, M. D., & Guan, Y. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00037-06 · Cited by 1,007
Influenza A Virus Lacking the NS1 Gene Replicates in Interferon-Deficient Systems
García-Sastre, A., Egorov, A., Matassov, D., Brandt, S., Levy, D. E., Durbin, J. E., Palese, P., & Muster, T. (1998) · Virology · doi:10.1006/viro.1998.9508 · Cited by 1,000
Self-citationA single amino acid in the PB2 gene of influenza A virus is a determinant of host range
Subbarao, E. K., London, W., & Murphy, B. R. (1993) · Journal of Virology · doi:10.1128/jvi.67.4.1761-1764.1993 · Cited by 933
Type 1 Interferons and the Virus-Host Relationship: A Lesson in Détente
García-Sastre, A., & Biron, C. A. (2006) · Science · doi:10.1126/science.1125676 · Cited by 885
Self-citationUpdate on Avian Influenza A (H5N1) Virus Infection in Humans
(2008) · New England Journal of Medicine · doi:10.1056/nejmra0707279 · Cited by 860
Rescue of Influenza A Virus from Recombinant DNA
Fodor, E., Devenish, L., Engelhardt, O. G., Palese, P., Brownlee, G. G., & García-Sastre, A. (1999) · Journal of Virology · doi:10.1128/jvi.73.11.9679-9682.1999 · Cited by 775
Self-citationSafety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine
Treanor, J. J., Campbell, J. D., Zangwill, K. M., Rowe, T., & Wolff, M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055778 · Cited by 698
Role of hemagglutinin cleavage for the pathogenicity of influenza virus.
Steinhauer, D. A. (1999) · Virology · doi:10.1006/viro.1999.9716 · Cited by 663
Mibayashi, M., Martínez-Sobrido, L., Loo, Y.-M., Cárdenas, W. B., Gale, M., & García-Sastre, A. (2007) · Journal of Virology · doi:10.1128/jvi.01265-06 · Cited by 576
Self-citationPandemic Threat Posed by Avian Influenza A Viruses
Horimoto, T., & Kawaoka, Y. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.1.129-149.2001 · Cited by 542
Jun-ichi, M., Satoshi, T., Kimi, A., Fumi, T., Akira, T., Kiyoshi, T., & Ken-ichi, Y. (1989) · Gene · doi:10.1016/0378-1119(89)90209-6 · Cited by 446
Multiple Anti-Interferon Actions of the Influenza A Virus NS1 Protein
Kochs, G., García-Sastre, A., & Martínez-Sobrido, L. (2007) · Journal of Virology · doi:10.1128/jvi.02581-06 · Cited by 445
Self-citationBresson, J.-L., Perronne, C., Launay, O., Gerdil, C., Saville, M., Wood, J., Höschler, K., & Zambon, M. C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68656-x · Cited by 411
Recombination Resulting in Virulence Shift in Avian Influenza Outbreak, Chile
Suarez, D. L., Senne, D. A., Banks, J., Brown, I. H., Essen, S. C., Lee, C.-W., Manvell, R. J., Mathieu-Benson, C., Moreno, V., Pedersen, J. C., et al. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1004.030396 · Cited by 346
Growth of H5N1 Influenza A Viruses in the Upper Respiratory Tracts of Mice
Hatta, M., Hatta, Y., Kim, J. H., Watanabe, S., Shinya, K., Nguyen, T., Lien, P. S., Le, Q. M., & Kawaoka, Y. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030133 · Cited by 335
Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach
Talon, J., Salvatore, M., O'Neill, R. E., Nakaya, Y., Zheng, H., Muster, T., García-Sastre, A., & Palese, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.070525997 · Cited by 320
Self-citationKawaoka, Y., Naeve, C. W., & Webster, R. G. (1984) · Virology · doi:10.1016/0042-6822(84)90376-3 · Cited by 319
Influenza virus a pathogenicity: The pivotal role of hemagglutinin
Webster, R. G., & Rott, R. (1987) · Cell · doi:10.1016/0092-8674(87)90321-7 · Cited by 276
Evolution and adaptation of H5N1 influenza virus in avian and human hosts in Indonesia and Vietnam
Smith, G. J. D., Naipospos, T. S. P., Nguyen, T. D., de Jong, M. D., Vijaykrishna, D., Usman, T. B., Hassan, S. S., Nguyen, T. V., Dao, T. V., Bui, N. A., et al. (2006) · Virology · doi:10.1016/j.virol.2006.03.048 · Cited by 252
Solórzano, A., Webby, R. J., Lager, K. M., Janke, B. H., García-Sastre, A., & Richt, J. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7535-7543.2005 · Cited by 252
Self-citationEngineered viral vaccine constructs with dual specificity: Avian influenza and Newcastle disease
Park, M., Steel, J., García‐Sastre, A., Swayne, D. E., & Palese, P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602566103 · Cited by 227
Self-citationRicht, J. A., Lekcharoensuk, P., Lager, K. M., Vincent, A. L., Loiacono, C. M., Janke, B. H., Wu, W.-H., Yoon, K.-J., Webby, R. J., Solórzano, A., et al. (2006) · Journal of Virology · doi:10.1128/jvi.00787-06 · Cited by 179
Self-citationMehle, A., & Doudna, J. A. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.06.007 · Cited by 171
Neumann, G., Fujii, K., Kino, Y., & Kawaoka, Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505587102 · Cited by 170
Naffakh, N., Massin, P., Escriou, N., Crescenzo-Chaigne, B., & van der Werf, S. (2000) · Microbiology · doi:10.1099/0022-1317-81-5-1283 · Cited by 162
Cauthen, A. N., Swayne, D. E., Sekellick, M. J., Marcus, P. I., & Suarez, D. L. (2006) · Journal of Virology · doi:10.1128/jvi.01667-06 · Cited by 92
Song, H., Ramírez, G., & Perez, D. R. (2007) · Journal of Virology · doi:10.1128/jvi.00893-07 · Cited by 89
Self-citation
Cited by
Programming the magnitude and persistence of antibody responses with innate immunity
Kasturi, S. P., Skountzou, I., Albrecht, R. A., Koutsonanos, D., Hua, T., Nakaya, H. I., Ravindran, R., Stewart, S., Alam, M., Kwissa, M., et al. (2011) · Nature · doi:10.1038/nature09737 · Cited by 975
Self-citationAdvances in the development of influenza virus vaccines
Krammer, F., & Palese, P. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4529 · Cited by 597
Self-citationThe 2009 A (H1N1) influenza virus pandemic: A review
Girard, M. P., Tam, J. S., Assossou, O. M., & Kieny, M. P. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.05.031 · Cited by 488
Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency
Ciancanelli, M. J., Huang, S. X. L., Luthra, P., Garner, H., Itan, Y., Volpi, S., Lafaille, F. G., Trouillet, C., Schmolke, M., Albrecht, R. A., et al. (2015) · Science · doi:10.1126/science.aaa1578 · Cited by 476
Self-citationTranscription Elongation Can Affect Genome 3D Structure
Heinz, S., Texari, L., Hayes, M. G. B., Urbanowski, M., Chang, M. W., Givarkes, N., Rialdi, A., White, K. M., Albrecht, R. A., Pache, L., et al. (2018) · Cell · doi:10.1016/j.cell.2018.07.047 · Cited by 453
Self-citation
Metadata
- Authors
- Steel, J., Lowen, A. C., Pena, L., Angel, M., Solórzano, A., Albrecht, R., Perez, D. R., García-Sastre, A., & Palese, P.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2009-02-15
- Volume
- 83
- Issue
- 4
- Pages
- 1742-1753
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2128025490
- Cited by
- 258
- References
- 31
- FWCI
- 10.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.